Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology

Dose-dependent effect of aspirin on the level of sphingolipids in human blood

(2013) M Knapp et al.   Advances in Medical Sciences

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

(2012) C Krakstad et al.   BRITISH JOURNAL OF CANCER

Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial

(2011) Emma J. Crosbie et al.   EUROPEAN JOURNAL OF CANCER

Proteomic analysis of stage I endometrial cancer tissue: Identification of proteins associated with oxidative processes and inflammation

(2011) G. Larry Maxwell et al.   GYNECOLOGIC ONCOLOGY

Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease

(2011) Marta Llauradó et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

(2010) E. J. Crosbie et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua

(2010) Z. Kolkova et al.   MOLECULAR HUMAN REPRODUCTION

Influence of body mass index on prognosis in gynecological malignancies

(2008) Karsten Münstedt et al.   CANCER CAUSES & CONTROL

Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction

(2008) M. Matsumoto et al.   ENDOCRINE-RELATED CANCER

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET

Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer

(2008) Tina Šmuc et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY